News

SBM Offshore Unveils Latest Share Repurchase Program Insights

SBM Offshore Unveils Latest Share Repurchase Program Insights

Recent Transactions in Share Repurchase Program

SBM Offshore is excited to share the latest updates on its EUR141 million share repurchase program covering the period from early to mid-November 2025. This initiative, valued at approximately USD 150 million, reflects the company's commitment to enhancing shareholder value.

Overview of the Share Repurchase Program

The current share buyback exercise is part of the broader EUR141 million program initiated in early 2025. The main goals of this initiative are twofold: to effectively reduce the share capital and ensure that shares are available for employee and management incentive plans.

Transaction Progress

As of mid-November, the cumulative total for the repurchases stands impressively at EUR 141,189,019. This reflects the ongoing commitment of SBM Offshore to strengthen its market position while returning value to shareholders.

Key Metrics

Here are some critical figures from the repurchase program thus far:

  • Total Repurchase Amount: EUR 141,189,019
  • Cumulative Repurchase Amount: EUR 100,467,785
  • Cumulative Quantity Repurchased: 4,668,106 shares
  • Average Repurchase Price: EUR 21.52
  • Program Completion Percentage: 71.16%

Insights from Recent Trading Days

In the five trading days leading up to November 12, 2025, several notable purchases contributed to the overall total:

Trading Highlights

  • November 6, 2025: 50,104 shares at EUR 21.81
  • November 7, 2025: 36,540 shares at EUR 21.79
  • November 10, 2025: 24,638 shares at EUR 22.00
  • November 11, 2025: 18,551 shares at EUR 21.96
  • November 12, 2025: 13,535 shares at EUR 22.50

These transactions highlight the active engagement of SBM Offshore in the market, showcasing a blend of strategic buying at varying prices aimed at optimizing stock performance.

Corporate Commitment and Strategy

As a leader in the offshore energy sector, SBM Offshore continues to demonstrate its dedication to sustainable energy solutions. By investing in share repurchases, the company aims to not just bolster its capital structure but also contribute positively to future growth prospects and shareholder satisfaction.

Corporate Vision

More than 7,800 employees worldwide collaborate towards delivering innovative solutions that align with SBM Offshore's mission of balancing ecological responsibility with economic growth. The company believes in creating cleaner and more efficient energy projects that contribute to a sustainable future.

For further details about the share repurchase program and more insights about SBM Offshore’s financial health and strategic direction, stakeholders are encouraged to visit the company's official resources.

Frequently Asked Questions

What is the primary goal of SBM Offshore's share repurchase program?

The primary goals are to reduce share capital and provide shares for employee management programs.

How much has SBM Offshore repurchased to date?

As of mid-November 2025, SBM Offshore has repurchased shares totaling EUR 141,189,019.

What is the average purchase price of repurchased shares?

The cumulative average repurchase price stands at EUR 21.52 per share as of the latest update.

How many shares have been repurchased cumulatively?

The total number of shares repurchased is 4,668,106.

Where can I find more information about SBM Offshore?

More details are available on SBM Offshore's website, where they provide ongoing updates on their operations and financial performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 273

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 79

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 290

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 133

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 189

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 675

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 188

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring AI's Impact on CRM Visibility and Brand Trust

Updated Category News Views 217

Understanding the Role of AI in CRM Visibility Brandi AI has recently launched its AI Visibility Index series, which offers insightful measurements of how industries are perceived in AI-generated responses. This new series highlights the ways in which customer relationship management (CRM) brands are represented through the lens of advanced AI answer engines. The AI...

Continue Reading
Celldex Therapeutics Thrives Amid Developments with Briquilimab

Updated Category News Views 148

Overview of Celldex Therapeutics and Briquilimab Celldex Therapeutics (NASDAQ: CLDX) is navigating an exciting phase as it explores treatments for chronic conditions like Chronic Inducible Urticaria (CIndU). Analysts have closely observed the efficacy of briquilimab, highlighting its performance through recent studies. Analyst Insights on Celldex and Briquilimab Goldman...

Continue Reading
XPENG's Financial Success in Q3 2024: Key Insights Revealed

Updated Category News Views 238

XPENG's Journey in the Third Quarter of 2024 XPeng Inc. (“XPENG” or “the Company,” NYSE: XPEV and HKEX: 9868) recently disclosed its financial results for the third quarter ended September 30, 2024. This marks a significant period showcasing growth in revenues and vehicle deliveries, reflecting the company's robust strategy in the smart electric vehicle market....

Continue Reading
Apple Inc. Beats Earnings Expectations: Analysts React

Updated Category News Views 144

Apple Inc. Overcomes Challenges with Strong Quarterly Results Apple Inc.‘s latest quarterly performance has generated significant buzz in the tech world. Analysts reveal that the results showcase a resilient company navigating through various market challenges. This performance not only reflects strong sales of products like the iPhone but also highlights impressive...

Continue Reading
Class Action Alert: Investors Have Rights with AMMO, Inc.

Updated Category News Views 237

Class Action Lawsuit Against AMMO, Inc. In a proactive move for investors, Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against AMMO, Inc. (NASDAQ: POWW). This suit comes in light of significant losses experienced by investors in the company due to alleged misstatements and omissions regarding its business practices. Understanding the Class...

Continue Reading